OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma
Shreya Badhrinarayanan, Christopher Cotter, Huaqi Zhu, et al.
Future Oncology (2024) Vol. 20, Iss. 28, pp. 2049-2057
Open Access | Times Cited: 8
Shreya Badhrinarayanan, Christopher Cotter, Huaqi Zhu, et al.
Future Oncology (2024) Vol. 20, Iss. 28, pp. 2049-2057
Open Access | Times Cited: 8
Showing 8 citing articles:
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Advancements in immunotherapy for hepatocellular carcinoma
S. Ascari, Rusi Chen, Caterina Vivaldi, et al.
Expert Review of Anticancer Therapy (2025) Vol. 25, Iss. 2, pp. 151-165
Closed Access
S. Ascari, Rusi Chen, Caterina Vivaldi, et al.
Expert Review of Anticancer Therapy (2025) Vol. 25, Iss. 2, pp. 151-165
Closed Access
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma
Huaikai Shi, Ta-Kun Yu, Ben Johnson, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Huaikai Shi, Ta-Kun Yu, Ben Johnson, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide
Vishnu Nagalapuram, Niveditha Popuri, Ryan David Nipp, et al.
JCO Oncology Practice (2025)
Closed Access
Vishnu Nagalapuram, Niveditha Popuri, Ryan David Nipp, et al.
JCO Oncology Practice (2025)
Closed Access
Evolving landscape of Systemic Therapy for Hepatocellular Carcinoma in 2025
Karan Kumar, Vivek A. Saraswat
Journal of Clinical and Experimental Hepatology (2025), pp. 102547-102547
Closed Access
Karan Kumar, Vivek A. Saraswat
Journal of Clinical and Experimental Hepatology (2025), pp. 102547-102547
Closed Access
Future perspectives on immunotherapy for hepatocellular carcinoma
Landon L. Chan, Stephen L. Chan
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Landon L. Chan, Stephen L. Chan
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Systemic Therapies for Advanced Hepatocellular Carcinoma: Which Gaps Should We Try to Fill?
Eleonora Cioli, Lorenzo Gervaso, Nicola Fazio
JCO Oncology Practice (2025)
Closed Access
Eleonora Cioli, Lorenzo Gervaso, Nicola Fazio
JCO Oncology Practice (2025)
Closed Access
Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results
Leonardo Stella, Clémence Hollande, Yasmina Ben Merabet, et al.
Expert Opinion on Emerging Drugs (2024)
Closed Access
Leonardo Stella, Clémence Hollande, Yasmina Ben Merabet, et al.
Expert Opinion on Emerging Drugs (2024)
Closed Access
Immunometabolic Targets in CD8+ T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma
Yu‐Hsuan Lin, Rexiati Ruze, Ruiqing Zhang, et al.
Liver Cancer (2024), pp. 1-30
Open Access
Yu‐Hsuan Lin, Rexiati Ruze, Ruiqing Zhang, et al.
Liver Cancer (2024), pp. 1-30
Open Access
